CCEL vs VMD: stock comparison and AI forecast
Cryo Cell International Inc (CCEL) and Viemed Healthcare, Inc. (VMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CCEL Cryo Cell International Inc
- Price
- $4.95 +38.3% · 6M
- Market Cap
- $40M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
VMD Viemed Healthcare, Inc.
- Price
- $9.13 -0.9% · 6M
- Market Cap
- $348M
- P/E Ratio
- 23.4x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- VMD is 8.7 times larger than CCEL by market capitalization ($348M against $40M).
- Over the last six months CCEL returned +38.3% and VMD -0.9%.
- VMD turns 5.0% of its revenue into net income, against -6.2% for CCEL.
- CCEL yields 8.10% in dividends; VMD pays none.
- Both companies share the SEC industry classification Services-Misc Health & Allied Services, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CCEL | VMD |
|---|---|---|
| Market Cap | $40M | $348M |
| P/E Ratio | – | 23.41x |
| P/B Ratio | – | 2.32x |
| Dividend Yield | 8.10% | – |
| EPS | $-0.23 | $0.39 |
| Book Value/Share | – | $3.94 |
| Revenue/Share | $3.86 | $8.15 |
| FCF/Share | $0.58 | $0.56 |
Profitability & Margins
| Metric | CCEL | VMD |
|---|---|---|
| ROE | – | 10.4% |
| ROA | -3.1% | 7.5% |
| ROIC | 0.4% | 15.0% |
| Gross Margin | 78.5% | 57.4% |
| Operating Margin | 0.6% | 7.8% |
| Net Margin | -6.2% | 5.0% |
| EBT Margin | -6.1% | 7.4% |
| Tax Rate | -1.9% | 29.2% |
Financial Health
| Metric | CCEL | VMD |
|---|---|---|
| Current Ratio | 0.86x | 1.25x |
| Quick Ratio | 0.82x | 1.16x |
| D/E Ratio | – | 0.37x |
| Financial Leverage | – | 1.38x |
| Interest Coverage | 5.0x | 59.0x |
| Working Capital | -$2M | $12M |
Cash Flow
| Metric | CCEL | VMD |
|---|---|---|
| Operating Cash Flow | $5M | $54M |
| Free Cash Flow | $5M | $21M |
| Capital Spending | -$270K | -$33M |
| OCF Growth YoY | -22.6% | 11.2% |
| FCF Growth YoY | -24.8% | 296.9% |
| FCF/Sales | 14.9% | 6.9% |
| CapEx/Sales | 0.9% | 10.5% |
Operational Efficiency
| Metric | CCEL | VMD |
|---|---|---|
| Asset Turnover | 0.50x | 1.49x |
| Receivables Turnover | 4.5x | 8.9x |
| Inventory Turnover | 12.5x | 29.0x |
| Fixed Assets Turnover | 1.5x | 4.1x |
| Days Sales Outstanding | 80 days | 41 days |
| Days Inventory | 29 days | 13 days |
| Payables Period | 132 days | – |
| Cash Conversion Cycle | -23 days | – |
Income Statement
| Metric | CCEL | VMD |
|---|---|---|
| Total Revenue | $31M | $310M |
| Operating Income | $190K | $24M |
| Net Income | -$2M | $16M |
| R&D Expense | $300K | $2M |
| SG&A Expense | $19M | $140M |
| Cost of Goods Sold | $7M | $132M |
Dividend & Shareholder Information
| Metric | CCEL | VMD |
|---|---|---|
| Dividends Per Share | $0.40 | – |
| Shares Outstanding | 8M | 38M |
| Net Income Growth | – | 14.8% |
| EPS Growth | -2400.0% | 44.4% |
CCEL vs VMD: stock comparison and AI forecast
Which is bigger, CCEL or VMD?
VMD is 8.7 times larger than CCEL by market capitalization ($348M against $40M).
Which stock performed better over the last six months, CCEL or VMD?
Over the last six months CCEL returned +38.3% and VMD -0.9%.
Which one does Intratio's AI model rank higher, CCEL or VMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.